Indian generic and formulation pharmaceutical (pharma) companies are contending with tariff-related challenges and subdued ...

The India Fund, Inc. fell by 5.80% (gross) in USD terms, outperforming the benchmark by 541bps in gross performance terms.

US President Donald Trump said countries including Britain had approached the United States to try to cut deals and avert the ...

India has emerged as a growing player in the illicit fentanyl trade, a new US intelligence report says, a designation likely ...

Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

Dr. Jitendra Singh, a renowned endocrinologist himself, emphasized the unique metabolic challenges faced by India due to its ...

The future of healthcare is not just new drugs; it is about smarter, more responsive solutions that prioritise patients ...

Indian Prime Minister Narendra Modi's government has decided to let lapse a $23 billion program to incentivize domestic ...